The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Open accessAbstract
Starvation blocks the actions of growth hormone (GH) and inhibits growth through mechanisms that are not well understood. In this report, we demonstrate that fibroblast growth factor 21 (FGF21), a hormone induced by fasting, causes GH resistance. In liver, FGF21 reduces concentrations of the active form of signal transducer and activator of transcription 5 (STAT5), a major mediator of GH actions, and causes corresponding decreases in the expression of its target genes, including insulin-like growth factor 1 (IGF-1). FGF21 also induces hepatic expression of IGF-1 binding protein 1 and suppressor of cytokine signaling 2, which blunt GH signaling. Chronic exposure to FGF21 markedly inhibits growth in mice. These data suggest a central role for FGF21 in inhibiting growth as part of its broader role in inducing the adaptive response to starvation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the observation that Fgf21 causes resistance to GH (Inagaki et al, 2008)”
From Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency (2018) · cites this paper as Inagaki et al, 2008
In the citing paper
“Given that high plasma concentrations of FGF21 have been observed to reduce growth hormone signaling, resulting in a marked growth defect (Inagaki et al, 2008)”
From Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency (2018) · cites this paper as Inagaki et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Nutritional Regulation of the Insulin-Like Growth Factors*
Thissen, J., Ketelslegers, J., & Underwood, L. E. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-80 · Cited by 1,575
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationBadman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418
Teglund, S., McKay, C., Schuetz, E. G., van Deursen, J. M., Stravopodis, D. J., Wang, D., Brown, M. P., Bodner, S. M., Grosveld, G. C., & Ihle, J. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81444-0 · Cited by 1,266
βKlotho is required for metabolic activity of fibroblast growth factor 21
Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., & Kuro-o, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701600104 · Cited by 617
Self-citationBinding proteins for the insulin-like growth factors: Structure, regulation and function
Baxter, R. C., & Martin, J. L. (1989) · Progress in Growth Factor Research · doi:10.1016/0955-2235(89)90041-0 · Cited by 568
Effect of Growth Hormone on Carbohydrate and Lipid Metabolism
Davidson, M. B. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-115 · Cited by 567
Guo, S., Rena, G., Cichy, S. B., He, X., Cohen, P., & Unterman, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17184 · Cited by 540
Cited by
Sorted by citations
Items 101–200 of 408
Henriksson, E., & Andersen, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.601349 · Cited by 97
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver
Cicione, C., Degirolamo, C., & Moschetta, A. (2012) · Hepatology · doi:10.1002/hep.25929 · Cited by 95
Wu, S., Levenson, A. E., Kharitonenkov, A., & Luca, F. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.343707 · Cited by 94
Bone health in anorexia nervosa
Misra, M., & Klibanski, A. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32834b4bdc · Cited by 93
FGF21: a novel prospect for the treatment of metabolic diseases.
Kharitonenkov, A., & Shanafelt, A. B. (2009) · PubMed · Cited by 91
Fibroblast Growth Factor-21 May Mediate Growth Hormone Resistance in Anorexia Nervosa
Fazeli, P. K., Misra, M., Goldstein, M. A., Miller, K. K., & Klibanski, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1730 · Cited by 90
Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production
Hine, C., Kim, H.-J., Zhu, Y., Harputlugil, E., Longchamp, A., Matos, M. S., Ramadoss, P., Bauerle, K. T., Brace, L. E., Asara, J. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.003 · Cited by 89
Bhattacharya, A., Sun, S., Wang, H., Liu, M. R., Long, Q., Yin, L., Kersten, S., Zhang, K., & Qi, L. (2018) · The EMBO Journal · doi:10.15252/embj.201899277 · Cited by 88
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
So, W. Y., & Leung, P. S. (2016) · Medicinal Research Reviews · doi:10.1002/med.21390 · Cited by 85
Murata, Y., Konishi, M., & Itoh, N. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/981315 · Cited by 87
Yamamoto, M., Iguchi, G., Fukuoka, H., Suda, K., Bando, H., Takahashi, M., Nishizawa, H., Seino, S., & Takahashi, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220606110 · Cited by 87
Shangguan, F., Zhou, H., Ma, N., Wu, S., Huang, H., Jin, G., Wu, S., Hong, W., Zhuang, W., Xia, H., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.697832 · Cited by 84
Sainsbury, A., & Zhang, L. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00948.x · Cited by 88
Mitochondrial uncoupling and longevity – A role for mitokines?
Klaus, S., & Ost, M. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110796 · Cited by 80
Role of Fibroblast Growth Factor 21 (FGF21) in Undernutrition-Related Attenuation of Growth in Mice
Kubicky, R. A., Wu, S., Kharitonenkov, A., & Luca, F. D. (2012) · Endocrinology · doi:10.1210/en.2011-1909 · Cited by 84
Cyphert, H. A., Alonge, K. M., Ippagunta, S. M., & Hillgartner, F. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094996 · Cited by 80
Kuro-o, M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy126 · Cited by 80
Iizuka, K. (2017) · Nutrients · doi:10.3390/nu9020181 · Cited by 79
Liu, Y., Zhao, C., Xiao, J., Liu, L., Zhang, M., Wang, C., Wu, G., Zheng, M.-H., Xu, L.-M., Chen, Y.-P., et al. (2016) · Scientific Reports · doi:10.1038/srep31026 · Cited by 78
Self-citationSo, W. Y., Cheng, Q., Xu, A., Lam, K. S. L., & Leung, P. S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.80 · Cited by 79
Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action
Ost, M., Coleman, V., Voigt, A., van Schothorst, E. M., Keipert, S., van der Stelt, I., Ringel, S., Graja, A., Ambrosi, T., Kipp, A. P., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2015.11.002 · Cited by 75
The Neuroendocrine Basis of Anorexia Nervosa and Its Impact on Bone Metabolism
Misra, M., & Klibanski, A. (2011) · Neuroendocrinology · doi:10.1159/000323771 · Cited by 81
Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis
Lakhani, I., Gong, M., Wong, W. T., Bazoukis, G., Lampropoulos, K. M., Wong, S. H., Wu, W. K. K., Wong, M. C. S., Ong, K. L., Liu, T., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.017 · Cited by 76
Diminished mTOR signaling: a common mode of action for endocrine longevity factors
Lamming, D. W. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-735 · Cited by 71
Plasma FGF21 displays a circadian rhythm during a 72‐h fast in healthy female volunteers
Andersen, B., Beck‐Nielsen, H., & Højlund, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04084.x · Cited by 74
Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up
Roselló‐Díez, A., & Joyner, A. L. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1048 · Cited by 78
Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
Zhang, J., & Li, Y. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.021 · Cited by 73
Carriquiry, M., Weber, W. J., Fahrenkrug, S. C., & Crooker, B. A. (2009) · Journal of Dairy Science · doi:10.3168/jds.2008-1676 · Cited by 73
Effects of Anorexia Nervosa on Bone Metabolism
Fazeli, P. K., & Klibanski, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00063 · Cited by 81
Babaknejad, N., Nayeri, H., Hemmati, R., Bahrami, S., & Esmaillzadeh, A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0623-2909 · Cited by 70
Khan, M. J., Jacometo, C. B., Graugnard, D. E., Corrêa, M. N., Schmitt, E., Cardoso, F. C., & Loor, J. J. (2014) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s14116 · Cited by 70
Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
Zhang, J., & Li, Y. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00168 · Cited by 70
Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis
Brahma, M. K., Adam, R. C., Pollak, N. M., Jaeger, D., Zierler, K. A., Poecher, N., Schreiber, R., Romauch, M., Moustafa, T., Eder, S., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m044784 · Cited by 70
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Li, H., Zhang, J., & Jia, W. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0244-8 · Cited by 67
Shahror, R. A., Linares, G. R., Wang, Y., Hsueh, S., Wu, C.-C., Chuang, D., Chiang, Y. H., & Chen, K. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2019.6422 · Cited by 69
Verzijl, C. R. C., van de Peppel, I. P., Struik, D., & Jonker, J. W. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1708898 · Cited by 67
The Effects of Nutrition on Linear Growth
Inzaghi, E., Pampanini, V., Deodati, A., & Cianfarani, S. (2022) · Nutrients · doi:10.3390/nu14091752 · Cited by 93
Hepatic CREB3L3 Controls Whole-Body Energy Homeostasis and Improves Obesity and Diabetes
Nakagawa, Y., Satoh, A., Yabe, S., Furusawa, M., Tokushige, N., Tezuka, H., Mikami, M., Iwata, W., Shingyouchi, A., Matsuzaka, T., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1113 · Cited by 66
HRD1‐ERAD controls production of the hepatokine FGF21 through CREBH polyubiquitination
Wei, J., Chen, L., Li, F., Yuan, Y., Wang, Y., Xia, W., Zhang, Y., Xu, Y., Yang, Z., Gao, B., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201898942 · Cited by 65
Andersen, B., Straarup, E. M., Heppner, K. M., Takahashi, D. L., Raffaele, V., Dissen, G. A., Lewandowski, K., Bödvarsdottir, T. B., Raun, K., Grove, K. L., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0080-7 · Cited by 66
FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans
Samms, R. J., Lewis, J. E., Norton, L., Stephens, F. B., Gaffney, C. J., Butterfield, T., Smith, D. P., Cheng, C. C., Perfield, J. W., Adams, A. C., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01257 · Cited by 65
Nutrients and Pathways that Regulate Health Span and Life Span
Pignatti, C., D’Adamo, S., Stefanelli, C., Flamigni, F., & Cetrullo, S. (2020) · Geriatrics · doi:10.3390/geriatrics5040095 · Cited by 68
Kralisch, S., Tönjes, A., Krause, K., Richter, J., Lössner, U., Kovacs, P. L., Ebert, T., Blüher, M., Stümvoll, M., & Faßhauer, M. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0367 · Cited by 64
FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs
Kim, K. H., & Lee, M. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0160 · Cited by 66
Chaudhari, A. B., Gupta, R., Patel, S. A., Velingkaar, N., & Kondratov, R. V. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-08-0624 · Cited by 65
Protein restriction and cancer
Yin, J., Ren, W., Huang, X., Li, T., & Yin, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.03.004 · Cited by 69
Miyake, M., Nomura, A., Ogura, A., Takehana, K., Kitahara, Y., Takahara, K., Tsugawa, K., Miyamoto, C., Miura, N., Sato, R., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-275990 · Cited by 62
Effect of Nutrition on Statural Growth
Gat‐Yablonski, G., & Luca, F. D. (2017) · Hormone Research in Paediatrics · doi:10.1159/000456547 · Cited by 63
Hine, C., Zhu, Y., Hollenberg, A. N., & Mitchell, J. R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7434 · Cited by 63
Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure
Katsumura, S., Siddiqui, N., Goldsmith, M. R., Cheah, J. H., Fujikawa, T., Minegishi, G., Yamagata, A., Yabuki, Y., Kobayashi, K., Shirouzu, M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.03.005 · Cited by 61
Self-citationEndocrinology of anorexia nervosa in young people
Singhal, V., Misra, M., & Klibanski, A. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000026 · Cited by 59
McIsaac, R. S., Lewis, K. N., Gibney, P. A., & Buffenstein, R. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13032 · Cited by 59
Liu, J., Foo, J. P., Liu, S., & Lim, S. C. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.032 · Cited by 58
Liao, C., & Kennedy, B. K. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-397920-9.00003-2 · Cited by 59
Streicher, C., Zeitz, U., Andrukhova, O., Rupprecht, A., Pohl, E. E., Larsson, T. E., Windisch, W. M., Lanske, B., & Erben, R. G. (2012) · Endocrinology · doi:10.1210/en.2011-1878 · Cited by 56
Inagaki, T. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00147 · Cited by 55
Self-citationSkeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
Sun, H., Sherrier, M. C., & Li, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.625287 · Cited by 54
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases
Yan, J., Nie, Y., Cao, J., Luo, M., Yan, M., Chen, Z., & He, B. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.655575 · Cited by 53
Ozaki, Y., Saito, K., Nakazawa, K., Konishi, M., Itoh, N., Hakuno, F., Takahashi, S.-I., Kato, H., & Takenaka, A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002846 · Cited by 51
Hashidume, T., Kato, A., Tanaka, T., Miyoshi, S., Itoh, N., Nakata, R., Inoue, H., Oikawa, A., Nakai, Y., Shimizu, M., et al. (2016) · Scientific Reports · doi:10.1038/srep28183 · Cited by 52
Gliniak, C. M., Gordillo, R., Youm, Y., Lin, Q., Crewe, C., Zhang, Z., Field, B. C., Fujikawa, T., Virostek, M., Zhao, S., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.05.011 · Cited by 53
Mehdi, S. F., Qureshi, M., Pervaiz, S., Kumari, K., Saji, E., Shah, M., Abdullah, A., Zahoor, K., Qadeer, H., Katari, D. K., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01074-z · Cited by 62
Fazeli, P. K., Faje, A. T., Cross, E. J., Lee, H., Rosen, C. J., Bouxsein, M., & Klibanski, A. (2015) · Bone · doi:10.1016/j.bone.2015.04.001 · Cited by 49
Mulyani, A. T., Khairinisa, M. A., Khatib, A., & Chaerunisaa, A. Y. (2025) · Nutrients · doi:10.3390/nu17091493 · Cited by 48
The NR4A nuclear receptors as potential targets for anti-aging interventions
Paillasse, M. R., & de Médina, P. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.12.003 · Cited by 47
Nonogaki, K., Hazama, M., & Satoh, N. (2014) · BioMed Research International · doi:10.1155/2014/751930 · Cited by 48
FGF-based drug discovery: advances and challenges
Chen, G., Chen, L., Li, X., & Mohammadi, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01125-w · Cited by 51
Self-citationAnorexia nervosa and bone metabolism
Fazeli, P. K., & Klibanski, A. (2014) · Bone · doi:10.1016/j.bone.2014.05.014 · Cited by 51
Kim, O. Y., Chung, J. Y., & Song, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104411 · Cited by 48
Metabolic roles of endocrine fibroblast growth factors
Fernandes-Freitas, I., & Owen, B. M. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.014 · Cited by 46
Missios, P., Zhou, Y., Guachalla, L. M., von Figura, G., Wegner, A., Chakkarappan, S. R., Binz, T. M., Gompf, A., Hartleben, G., Burkhalter, M. D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5924 · Cited by 49
Oshida, K., Vasani, N. B., Waxman, D. J., & Corton, J. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148308 · Cited by 48
McCarty, M. F., & DiNicolantonio, J. J. (2015) · Open Heart · doi:10.1136/openhrt-2014-000205 · Cited by 48
Yu, J., Zhao, L., Wang, A., Eleswarapu, S., Ge, X., Chen, D., & Jiang, H. (2011) · Endocrinology · doi:10.1210/en.2011-1591 · Cited by 45
Metabolic actions of fibroblast growth factor 21
Ramos, D. C., Aguilar-Salinas, C. A., & Gomez-Perez, F. J. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283557d22 · Cited by 46
Wu, S., Grunwald, T., Kharitonenkov, A., Dam, J., Jockers, R., & Luca, F. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462218 · Cited by 45
RetractedDietary protein and amino acid restriction: Roles in metabolic health and aging-related diseases
Wang, D., Ye, J., Shi, R., Zhao, B., Liu, Z., Lin, W. J., & Liu, X. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.009 · Cited by 46
The influence of skeletal muscle on appetite regulation
Grannell, A., VITO, G. D., Murphy, J. C., & le Roux, C. W. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1618185 · Cited by 46
Anorexia Nervosa: A Unified Neurological Perspective
Hasan, T. F., & Hasan, H. (2011) · International Journal of Medical Sciences · doi:10.7150/ijms.8.679 · Cited by 50
Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR)
Cheng, X., Vispute, S. G., Liu, J., Cheng, C., Kharitonenkov, A., & Klaassen, C. D. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.013 · Cited by 42
Zhang, J., & Li, Y. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.007 · Cited by 44
Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency
Zarei, M., Barroso, E., Leiva, R., Barniol‐Xicota, M., Pujol, E., Escolano, C., Vázquez, S., Palomer, X., Pardo, V., González‐Rodríguez, Á., et al. (2016) · Diabetes · doi:10.2337/db16-0155 · Cited by 42
Curcumin and dietary polyphenol research: beyond drug discovery
Jin, T. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.179 · Cited by 43
Endocrine fibroblast growth factors as regulators of metabolic homeostasis
Kurosu, H., & Kuro‐o, M. (2009) · BioFactors · doi:10.1002/biof.12 · Cited by 41
Growth Hormone Resistance—Special Focus on Inflammatory Bowel Disease
Soendergaard, C., Young, J. A., & Kopchick, J. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051019 · Cited by 44
Li, H., Sun, H., Qian, B., Feng, W. H., Carney, D., Miller, J. P., Hogan, M. V., & Wang, L. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3932 · Cited by 41
Frailty and HIV: Moving from Characterization to Intervention
Erlandson, K. M., & Piggott, D. A. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00554-1 · Cited by 44
Gahete, M. D., Córdoba‐Chacón, J., Luque, R. M., & Kineman, R. D. (2012) · Endocrinology · doi:10.1210/en.2012-1849 · Cited by 41
Targeting Neurovascular Interaction in Retinal Disorders
Fu, Z., Sun, Y., Cakir, B., Tomita, Y., Huang, S., Wang, Z., Liu, C., Cho, S. S., Britton, W. R., Kern, T. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041503 · Cited by 43
Morbid obesity attenuates the skeletal abnormalities associated with leptin deficiency in mice
Turner, R. T., Philbrick, K. A., Wong, C. P., Olson, D. A., Branscum, A. J., & Iwaniec, U. T. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0224 · Cited by 39
FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations
Morón‐Ros, S., Uriarte, I., Berasain, C., Avila, M. A., Sabater, M., Moreno‐Navarrete, J. M., Fernández‐Real, J. M., Giralt, M., Villarroya, F., & Gavaldà‐Navarro, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101113 · Cited by 40
Sasaki, K., Uchiumi, T., Toshima, T., Yagi, M., Do, Y., Hirai, H., Igami, K., Gotoh, K., & Kang, D. (2020) · Bioscience Reports · doi:10.1042/bsr20201289 · Cited by 42
FGF21 and Chronic Kidney Disease.
Salgado, J., Goes, M. A., & Salgado, N. (2021) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2021.154738 · Cited by 35
Fibroblast growth factor 21 has no direct role in regulating fertility in female mice
Singhal, G., Douris, N., Fish, A. J., Zhang, X., Adams, A. C., Flier, J. S., Pissios, P., & Maratos-Flier, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.010 · Cited by 38
Liver Brain Interactions: Focus on FGF21 a Systematic Review
Prida, E., Álvarez-Delgado, S., Pérez-Lois, R., Soto-Tielas, M., Estany‐Gestal, A., Fernø, J., Seoane, L. M., Quiñones, M., & Al–Massadi, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113318 · Cited by 40
The role of the fibroblast growth factor family in bone‐related diseases
Wang, J., Liu, S., Li, J., & Yi, Z. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13588 · Cited by 38
Backstage of Eating Disorder—About the Biological Mechanisms behind the Symptoms of Anorexia Nervosa
Skowron, K. P., Kurnik‐Łucka, M., Dadański, E., Bętkowska-Korpała, B., & Gil, K. (2020) · Nutrients · doi:10.3390/nu12092604 · Cited by 41
Guasti, L., Silvennoinen, S., Bulstrode, N., Ferretti, P., Sankilampi, U., & Dunkel, L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1566 · Cited by 38
Morita, M., Siddiqui, N., Katsumura, S., Rouya, C., Larsson, O. S., Nagashima, T., Hekmatnejad, B., Takahashi, A., Kiyonari, H., Zang, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816023116 · Cited by 37
Ritchie, M. M., Hanouneh, I. A., Noureddin, M., Rolph, T., & Alkhouri, N. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1718104 · Cited by 37
Metadata
- Authors
- Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Howard Hughes Medical Institute (US)
- New York University (US)
- Corresponding author
- Kliewer, Steven A.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 8
- Issue
- 1
- Pages
- 77-83
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC2575072
- OpenAlex
- W2114836473
- Cited by
- 409
- References
- 37
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 22 · 2023: 12 · 2022: 21 · 2021: 35 · 2020: 22 · 2019: 27 · 2018: 22 · 2017: 18 · 2016: 31 · 2015: 44 · 2014: 44 · 2013: 19 · 2012: 26
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences (RL1GM084436)
- National Institute of Diabetes and Digestive and Kidney Diseases (PL1DK081182)
- National Institute of Dental and Craniofacial Research (DE13686, R01DE013686)
- National Center for Research Resources (P20RR020691)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- FGF21, growth hormone signaling, fasting, starvation, growth inhibition, STAT5, insulin-like growth factor I, SOCS2, hepatic gene expression
- MeSH terms
- Adaptation, Physiological, Animals, Fasting, Fibroblast Growth Factors, Growth, Liver, Growth Hormone, Starvation, Signal Transduction, STAT5 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
